Press release
Irritable Bowel Syndrome (IBS) Treatment Market Analysis 2021 Global Insights, Industry Demand, Size, Type, Application, Trends, Outlook 2028
The "Irritable Bowel Syndrome (IBS) Treatment Market Forecast to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Irritable Bowel Syndrome (IBS) Treatment Market with detailed market segmentation by drug type, distribution channel, and geography. The Global Irritable Bowel Syndrome (IBS) Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Irritable Bowel Syndrome (IBS) Treatment Market players and offers key trends and opportunities in the market.The market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028.
Download FREE Sample Report At - https://www.theinsightpartners.com/sample/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The report covers key developments in the Irritable Bowel Syndrome (IBS) Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Irritable Bowel Syndrome (IBS) Treatment Market are anticipated to lucrative growth opportunities in the future with the rising demand for Irritable Bowel Syndrome (IBS) Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Irritable Bowel Syndrome (IBS) Treatment Market.
Top Key Players are covered in this report:
• Ironwood Pharmaceuticals, Inc.
• AbbVie.
• Sebela Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• Alfasigma S.p.A.
• Astellas Pharma Inc.
• AstraZeneca
• Synthetic Biologics, Inc.
• Bausch + Lomb Incorporated
• Lannett Company Inc
Regional Assessment:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Irritable Bowel Syndrome (IBS) Treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Irritable Bowel Syndrome (IBS) Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Feel Free to Ask Your Queries At - https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The report segments global irritable bowel syndrome (IBS) treatment market as Follows:
By Type
• IBS with Diarrhea (IBS-D)
• IBS with Constipation (IBS-C)
• Mixed IBS (IBS-M)
By Product
• Rifaximin
• Eluxadoline
• Linaclotide
• Lubiprostone
• Others
By Distribution Channel
• Hospitals Pharmacies
• Drug Stores and Retail Pharmacies
• Online Pharmacies
This Irritable Bowel Syndrome (IBS) Treatment Report Provides a superior market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviors. This market research study presents actionable market insights with which sustainable and money-spinning business strategies can be created.
Interested In Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPRE00006814/?utm_source=OpenPR&utm_medium=10741
The essential aspects like the latest market dynamics, development trends, and growth opportunities are presented, along with industry barriers, developmental threats, and risk factors. The report provides a concise market view that will provide ease of understanding. Also, the study presents the analytical depiction of the global market industry with the current and future estimations of the market.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome (IBS) Treatment Market Analysis 2021 Global Insights, Industry Demand, Size, Type, Application, Trends, Outlook 2028 here
News-ID: 3066234 • Views: …
More Releases from The Insight Partners

Bovine Blood Plasma Derivatives Market Estimated to Experience a Hike in Growth …
To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions. The biopharmaceutical sector is a primary growth driver for the bovine blood plasma derivatives market. These derivatives are essential in the production of vaccines, monoclonal antibodies, and therapies for blood disorders. As pharmaceutical companies innovate and expand their product lines, the demand for high-quality plasma-derived products continues to rise, supporting market…

UV Spectroscopy Market Global Rising Demand & Huge Scope Till 2031
The continuous development of UV spectroscopy technology to improve sensitivity, accuracy, and efficiency is driving the market. UV spectroscopy's ability to analyze complex samples is expanding its use in industries like pharmaceuticals, environmental testing, and food safety. To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions. To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections,…

Cocktail Strainer Market Stirred by Home Barware Boom
New York, US -The global Cocktail Strainer Market is transforming, as detailed in a recent publication by The Insight Partners titled Cocktail Strainer Market Share, Size, Trends, and Forecast by 2031. The report emphasizes how consumer preferences for high-end materials, thoughtful design, and artisan craftsmanship are redefining how cocktail strainers are produced and purchased.
This shift is not just cosmetic. The increasing demand for quality and presentation is helping fuel significant…

Cloud VPN Market Thrives on AI and Remote Access Demand
New York, US - September 4, 2025 - The Insight Partners has unveiled its latest Cloud VPN Market report, highlighting a period of sustained growth for the global VPN industry. As organizations across sectors embrace digital transformation, the Cloud VPN Market size is expanding rapidly, driven by the convergence of AI-enhanced security, cloud-native infrastructure, and remote work models.
The report, titled Cloud VPN Market Share, Size, Trends, and Forecast by 2031,…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning.
This also includes consulting services concerning railway systems issues, such as travel…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…